Clinical outcomes in patients with pemphigus vulgaris receiving a combination rituximab and intravenous immunoglobin therapy protocol
Thesis (M.A.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis or dissertation. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would...
Main Author: | Zakka, Labib |
---|---|
Language: | en_US |
Published: |
Boston University
2015
|
Online Access: | https://hdl.handle.net/2144/12694 |
Similar Items
-
Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
by: Sharon Baum, et al.
Published: (2020-10-01) -
Four cases of recalcitrant pemphigus vulgaris salvaged with rituximab
by: Samyak Ganjre, et al.
Published: (2017-01-01) -
Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.
by: Ashwin Agarwal, et al.
Published: (2018-01-01) -
Delayed-onset serum sickness due to rituximab in pemphigus vulgaris
by: Ajay Deshpande
Published: (2019-01-01) -
Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
by: Gabrielle Benesh, BS, et al.
Published: (2021-10-01)